NCGC s Jim Inglese on Small-Molecule Cell-Based Screening at the NIH | GenomeWeb

At A Glance

Name: Jim Inglese

Position: Director, Biomolecular Screening and Profiling, NIH Chemical Genomics Center (NCGC); Editor-in-Chief, Assay and Drug Development Technology

Background: Senior research fellow, Merck Research Laboratories — 1999-2004; Senior research fellow, Pharmacopeia — 1995-1999; Postdoc, Howard Hughes Medical Institute, Duke University — 1989-1994; PhD, organic chemistry, Pennsylvania State University — 1989; BS, chemistry, Rensselaer Polytechnic Institute — 1984

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.